Thank you, Brett. Good afternoon to everyone, and thank you for joining us. As previously disclosed, the company held its Annual Meeting of Stockholders on December 19, 2024. And as a result, six directors were elected: Andy Levy, John Moore, Walter Schenker, Alex Shen, General Gene Renuad and Rob Straus. On December 23, 2024, the Board appointed by unanimous vote General Gene Renoir to serve as Chair of the Board and Rob Straus to serve as Vice Chair of the Board. Effective January 13, 2025, John Moore resigned as a member of the Board of Directors to focus on his other responsibilities. The Board has decided not to fill the vacancy created by Mr. Moore's resignation at this time. The composition of committees of the Board is as follows. The audit committee members are Andy Levy, General Gene Renaud and Walter Schenker. Walter Schenker is the Chair. The compensation committee members are Andy Levy and Rob Strauss. Andy Levy is the Compensation Committee Chair. The Nominating and Governance Committee members are General Gene Renuad, Walter Schenker and Rob Straus. Rob Straus is the Chair of the Nominating and Governance Committee. I would like to share some remarks from our Board Chair, General Gene Renuad and our Board Vice Chair, Rob Straus. The Board of Directors is committed to improve transparency for its stockholders, including the return to timely SEC filings. Enhanced accountability policies should drive better financial performance. A renewed focus on existing operations is an immediate priority, especially at Stadco, but also at Ranor. All directors are working constructively together to maximize stockholder value. As for myself as the CEO and the Board Director, I'm looking forward to forging ahead, constructively and with alignment. As a matter of fact, General Gene Renuad and Rob Strauss will both be on-site at Stadco on February 10 for an in person eyeball review of the operations to help establish a firm understanding and to enable a fact based operations focus. One item additionally, on January 15, 2025, Richard Roomberg, Chief Financial Officer of the company notified the company that he will resign from all roles with the company and its subsidiaries effective as of February 14, 2025. Mr. Roomberg’s resignation is not due to any disagreement with the company on any matter related to the company's operations, policies or practices. Mr. Roomberg’s replacement will be announced in due course. Okay. Next we return to our earnings call format. Well, starting off with second quarter at Stadco, revenue was $4.2 million or a 17% increase compared to the same period a year ago. 2nd quarter Ranor revenue was $4.8 million compared to $4.5 million a year ago. The second quarter consolidated revenue was $8.9 million or 12% higher when compared to revenue of $8 million for the same period one year ago. Consolidated gross profit was 2% lower when compared to the same period a year ago. Second Stadco operating loss of $0.8 million resulted from unexpected higher manufacturing costs on one-off projects. Legacy pricing problems on core business, machine breakdowns in the quarter that disrupted expected throughput and under absorbed overhead costs. Ranor had operating profit of $1 million in the second quarter, primarily due to favorable project mix. Customer confidence remains high as our consolidated backlog was $48.6 million at September 30, 2024. We expect to deliver our strong backlog over the course of the next one to three fiscal years with gross margin expansion. We remain highly focused on cash management, a critical piece of risk mitigation and continue to manage and control expenses, capital expenditures, customer advances, progress billings and final invoicing at shipment. And now I would like to turn the call over to our CFO, Richard Roomberg to continue with the review of our Q2 results. Richard?